| 000 | 01586 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513203128.0 | ||
| 264 | 0 | _c20000308 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0028-1298 | ||
| 024 | 7 |
_a10.1007/s002109900167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrondin, R | |
| 245 | 0 | 0 |
_aNoradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cFeb 2000 |
||
| 300 |
_a181-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenergic alpha-2 Receptor Antagonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIdazoxan _xtherapeutic use |
| 650 | 0 | 4 |
_aLevodopa _xtoxicity |
| 650 | 0 | 4 |
_aMPTP Poisoning _xdrug therapy |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xphysiology |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aHadj Tahar, A | |
| 700 | 1 | _aDoan, V D | |
| 700 | 1 | _aLadure, P | |
| 700 | 1 | _aBédard, P J | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 361 _gno. 2 _gp. 181-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002109900167 _zAvailable from publisher's website |
| 999 |
_c10640153 _d10640153 |
||